CHOLAFIN – Cholamandalam Investment and Finance Company – Q4 FY26 Financial Results – 30-Apr-26

Cholamandalam’s FY27 entry shows 22.8% PAT growth, diversified loan book, and Q4 acceleration. LAP/Home Loans scale profitably, but credit costs up 41.8% and derivative exposure spike threaten margins. NIM trends, Stage‑2/3 assets, and credit cost normalization will decide if valuation premium holds.

4–6 minutes


🔍 Observations

Topline

  • Total Income rose 20.6% YoY (₹26,152.56 Cr → ₹31,538.73 Cr in FY26), driven primarily by Interest Income up 19.6% (₹23,747.74 Cr → ₹28,403.26 Cr).
  • Fee & Commission Income surged 21.6% YoY (₹1,739.08 Cr → ₹2,114.21 Cr), signaling strong disbursement volumes and cross-sell momentum.
  • Q4 FY26 Total Income of ₹8,563.54 Cr grew 20.0% YoY and 6.9% QoQ — sequential acceleration intact.

Bottomline

  • PAT grew 22.8% YoY (₹4,262.70 Cr → ₹5,232.61 Cr); Q4 FY26 PAT of ₹1,645.20 Cr jumped 30.6% YoY and 27.5% QoQ — strong exit momentum.
  • Basic EPS expanded 22.2% YoY (₹50.72 → ₹61.98), with share count near-flat, confirming earnings quality is not dilution-driven.
  • Tax rate was effectively stable (~25%), with deferred tax credits (₹269.65 Cr) providing modest PAT support.

Margins

  • PBT Margin (PBT/Total Income): FY26 = 22.1% vs FY25 = 22.0% — near-flat, suggesting cost growth is tracking revenue growth.
  • Net Profit Margin: FY26 = 16.6% vs FY25 = 16.3% — marginal improvement; financing costs (45.6% of total income) remain the dominant margin lever.
  • Impairment costs rose disproportionately — 41.8% YoY (₹2,494.31 Cr → ₹3,536.34 Cr) vs revenue growth of 20.6% — compressing credit-adjusted spreads.

Growth Trajectory

  • Loan book expanded 19.6% YoY (₹1,82,037.64 Cr → ₹2,17,743.72 Cr), sustaining the AUM compounding needed to drive future interest income.
  • LAP segment delivered standout PBT growth of 54.6% YoY (₹1,396.43 Cr → ₹2,158.97 Cr), becoming the second-largest profit contributor.
  • Home Loans PBT grew 23.7% YoY (₹693.12 Cr → ₹857.36 Cr) — scaling fast off a smaller base, adding segment diversification.



🧮 Profit & Loss Statement


🧮 Balance Sheet


🧮 Cash Flows Statement


🟢 Green Flags

  • PAT up 30.6% YoY in Q4 FY26 — strongest quarterly print, signals margin recovery and operating leverage kicking in.
  • LAP PBT CAGR-like surge of 54.6% YoY — high-yield secured segment scaling fast, accretive to blended margins.
  • Loan book at ₹2.18L Cr, up 19.6% YoY — AUM growth at this scale signals durable topline visibility for FY27.
  • Total Equity up 28.7% YoY (₹23,668.69 Cr → ₹30,458.40 Cr) — capital base expanding ahead of asset growth, improving solvency cushion.
  • Cash & equivalents up 57.5% YoY (₹5,279.65 Cr → ₹8,314.85 Cr) — strong liquidity buffer reduces refinancing risk in a tight rate environment.
  • Fee income growing at 21.6% YoY — non-interest revenue diversification lowers dependence on pure NIM.
  • EPS of ₹61.98 in FY26 vs ₹50.72 in FY25 — 22.2% EPS growth with minimal equity dilution reflects high capital efficiency.

🔴 Red Flags

  • Impairment costs at ₹3,536.34 Cr, up 41.8% YoY — growing nearly 2x faster than revenue; asset quality stress is broadening.
  • Finance costs at ₹14,384.13 Cr = 45.6% of Total Income — cost of funds remaining structurally elevated; NIM compression risk persists if rates stay high.
  • Operating cash outflow of ₹30,020.80 Cr in FY26 — negative OCF is structural for NBFCs, but the scale of outflow requires sustained wholesale funding access.
  • Total borrowings at ₹2,11,069.61 Cr (Debt Securities ₹40,824.10 Cr + Other Borrowings ₹1,56,542.80 Cr + Sub Debt ₹13,702.71 Cr) vs Equity of ₹30,458.40 Cr — leverage ratio ~6.9x; thin equity buffer against credit shocks.
  • Derivative Financial Instruments (Asset) jumped to ₹1,701.06 Cr from ₹203.32 Cr — a 736% spike; mark-to-market volatility exposure has increased materially.
  • “Others” segment PBT fell 8.6% YoY (₹585.05 Cr → ₹534.66 Cr) — only segment declining; warrants monitoring on mix and profitability.
  • Net gain on fair value change fell 43.3% YoY (₹196.57 Cr → ₹111.38 Cr) — market-linked income less supportive in FY26.

📊 Balance Sheet Analysis

  • Loan book quality risk: Impairment of ₹3,536.34 Cr against a loan book of ₹2,17,743.72 Cr implies ~1.62% credit cost — manageable but rising; trajectory matters more than absolute level.
  • Leverage elevated but sector-normal: Debt-to-Equity at ~6.9x is high in absolute terms but standard for a deposit-free NBFC; however, any AUM growth slowdown would pressure ROE math quickly.
  • Liquidity strong: Cash + Bank Balances = ₹14,695.08 Cr (₹8,314.85 Cr + ₹6,380.23 Cr) against short-term obligations — adequate near-term buffer.
  • Equity accretion healthy: ₹1,468.07 Cr raised via share issuance in FY26 alongside ₹5,232.61 Cr PAT retention — balance sheet self-funding at a healthy clip.

💰 Cash Flow Analysis

  • OCF deeply negative at –₹30,020.80 Cr — entirely loan disbursement-driven (Loans consumed ₹45,120.59 Cr); characteristic of high-growth NBFC, not a distress signal in isolation.
  • Financing cash inflows of ₹35,610.01 Cr funded the OCF gap — net debt issuance remains the growth engine, making wholesale market access a critical dependency.
  • Investing outflow reduced to –₹2,554.01 Cr from –₹2,948.12 Cr — incremental capex discipline maintained; fixed asset investments modest relative to AUM scale.
  • Free cash flow not meaningful here — for an NBFC, loan disbursements are core operations; the relevant signal is the funding mix and asset-liability match, not traditional FCF.

💡 Investment Outlook

Cholamandalam enters FY27 with a strong earnings trajectory — 22.8% PAT growth, a diversifying loan book, and an accelerating Q4 exit — all pointing to durable compounding.

The LAP and Home Loan segments are scaling fast and adding profitable diversification beyond the core vehicle finance franchise.

Key risks to monitor are the disproportionate rise in credit costs (impairment up 41.8% vs revenue up 20.6%) and the significant derivative exposure spike, both of which could weigh on margins if macro conditions deteriorate.

Investors should track NIM trends, Stage-2/3 asset disclosures, and the pace of credit cost normalization in FY27 to assess whether the current valuation premium is sustainable.


Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.


Discover more from ChartAlert®

Subscribe now to keep reading and get access to the full archive.

Continue reading

Discover more from ChartAlert®

Subscribe now to keep reading and get access to the full archive.

Continue reading